BIOPHARMA
By
Does a New Kidney Cancer Trial Expand Long-Term Oncology Optionality for Bristol-Myers Squibb and BioNTech?
December 2025 — Bristol-Myers Squibb and BioNTech have announced progress in their oncology collaboration with the initiation of…
Is Gilead’s Experimental HIV Treatment Matching the Efficacy of Its Blockbuster Drug in Late-Stage Trials?
Foster City, California — Gilead Sciences has reported that its experimental HIV treatment has met the primary goal…
Is the White House (Trump) Expanding Its Drug Price Reduction Strategy with the Largest Round of Agreements Yet?
Washington, D.C. — The U.S. administration has announced a new set of agreements with nine pharmaceutical companies to…
Is Sanofi Strengthening Its Alzheimer’s Pipeline with a $1.04 Billion Partnership with South Korea’s ADEL?
Paris – Sanofi, the global pharmaceutical company, has announced a strategic collaboration with South Korea-based biotech ADEL to…
Is Theremia Using AI to Unlock Next-Generation Immuno-Oncology Therapies and Advance Pharma Partnerships?
Strategic Overview Theremia is emerging as a pioneering AI-driven biotech focused on immune system modulation for oncology, integrating…
Is Karyon Bio Using AI to Decode Disease Networks as Biopharma Moves Beyond Single-Target Drug Discovery?
Strategic Overview Karyon Bio is emerging as a next-generation AI-driven biotech focused on one of the industry’s most…
